MedPath

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia
Ownership
-
Established
1876-01-01
Employees
19.4K
Market Cap
-
Website
https://www.jhu.edu/

Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI)

Completed
Conditions
Coronavirus
First Posted Date
2020-08-03
Last Posted Date
2022-01-14
Lead Sponsor
Johns Hopkins University
Target Recruit Count
702
Registration Number
NCT04496466
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial

Completed
Conditions
Tuberculosis Prevention
Tuberculosis Infection
First Posted Date
2020-07-31
Last Posted Date
2023-07-12
Lead Sponsor
Johns Hopkins University
Target Recruit Count
183
Registration Number
NCT04494516
Locations
🇪🇹

KNCV Tuberculosis Foundation, Addis Ababa, Ethiopia

🇿🇦

The Aurum Institute, Johannesburg, South Africa

Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye

Completed
Conditions
Ocular Surface Disease
Sjogren's Syndrome
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Interventions
Diagnostic Test: Questionnaires
Diagnostic Test: Tear fluid sampling
Diagnostic Test: Impression Cytology
First Posted Date
2020-07-30
Last Posted Date
2023-01-05
Lead Sponsor
Johns Hopkins University
Target Recruit Count
92
Registration Number
NCT04493658
Locations
🇺🇸

Wilmer Eye Insitute, Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia

Not Applicable
Withdrawn
Conditions
Primary Progressive Aphasia
Interventions
Device: Active tDCS plus Speech-Language Therapy
Device: Sham plus Speech-Language Therapy
First Posted Date
2020-07-24
Last Posted Date
2025-04-24
Lead Sponsor
Johns Hopkins University
Target Recruit Count
60
Registration Number
NCT04486586
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique

Not Applicable
Completed
Conditions
Lung Diseases
Interventions
Device: ERBECRYO® 2 Cryosurgical Unit and Accessories - K190651
First Posted Date
2020-07-24
Last Posted Date
2022-02-25
Lead Sponsor
Johns Hopkins University
Target Recruit Count
51
Registration Number
NCT04486560
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial

Phase 2
Active, not recruiting
Conditions
COVID-19
Interventions
Other: Placebo Saline
First Posted Date
2020-07-22
Last Posted Date
2024-03-28
Lead Sponsor
Johns Hopkins University
Target Recruit Count
33
Registration Number
NCT04482621
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Recruiting
Conditions
Pancreas Cancer
Pancreatic Neoplasms
First Posted Date
2020-07-16
Last Posted Date
2025-02-12
Lead Sponsor
Johns Hopkins University
Target Recruit Count
5000
Registration Number
NCT04473794
Locations
🇺🇸

The Johns Hopkins Hospital, Baltimore, Maryland, United States

Prevent TB: Choice Architecture for TPT Delivery

Not Applicable
Recruiting
Conditions
Tuberculosis
HIV/AIDS
Interventions
Behavioral: Choice Architecture
First Posted Date
2020-07-10
Last Posted Date
2025-01-23
Lead Sponsor
Johns Hopkins University
Target Recruit Count
36
Registration Number
NCT04466488
Locations
🇿🇦

Perinatal HIV Research Unit, Soweto, Gauteng, South Africa

Choice Architecture Based TB Preventive Therapy Prescribing

Not Applicable
Completed
Conditions
Tuberculosis
HIV/AIDS
Interventions
Behavioral: Choice Architecture
First Posted Date
2020-07-10
Last Posted Date
2022-11-17
Lead Sponsor
Johns Hopkins University
Target Recruit Count
57
Registration Number
NCT04466293
Locations
🇲🇿

Aurum Institute, Maputo, Mozambique

🇿🇼

Clinton Health Access Initiative, Harare, Zimbabwe

🇲🇼

KNCV Tuberculosis Foundation, Lilongwe, Malawi

Outcomes After Transoral Incisionless Fundoplication (TIF) Following Successful Endoscopic Ablation for Barrett's Esophagus

Conditions
Transoral Incisionless Fundoplication
Barrett Esophagus
Interventions
Device: TIF
First Posted Date
2020-07-07
Last Posted Date
2024-06-13
Lead Sponsor
Johns Hopkins University
Target Recruit Count
50
Registration Number
NCT04457193
Locations
🇺🇸

Saowanee Ngamruengphong, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath